Annual CFI:
-$109.71M+$113.92M(+50.94%)Summary
- As of today, AKRO annual cash from investing is -$109.71 million, with the most recent change of +$113.92 million (+50.94%) on December 31, 2024.
- During the last 3 years, AKRO annual cash from investing has fallen by -$151.99 million (-359.48%).
- AKRO annual cash from investing is now -359.48% below its all-time high of $42.28 million, reached on December 31, 2021.
Performance
AKRO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$79.34M+$561.52M(+116.45%)Summary
- As of today, AKRO quarterly cash from investing is $79.34 million, with the most recent change of +$561.52 million (+116.45%) on June 30, 2025.
- Over the past year, AKRO quarterly cash from investing has increased by +$335.24 million (+131.00%).
- AKRO quarterly cash from investing is now at all-time high.
Performance
AKRO Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$314.50M+$335.24M(+51.60%)Summary
- As of today, AKRO TTM cash from investing is -$314.50 million, with the most recent change of +$335.24 million (+51.60%) on June 30, 2025.
- Over the past year, AKRO TTM cash from investing has dropped by -$3.55 million (-1.14%).
- AKRO TTM cash from investing is now -558.77% below its all-time high of $68.55 million, reached on June 30, 2022.
Performance
AKRO TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AKRO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +50.9% | +131.0% | -1.1% |
| 3Y3 Years | -359.5% | +568.4% | -558.8% |
| 5Y5 Years | -53.4% | +106.3% | -217.1% |
AKRO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -359.5% | +50.9% | at high | +116.5% | -733.8% | +51.6% |
| 5Y | 5-Year | -359.5% | +50.9% | at high | +116.5% | -558.8% | +51.6% |
| All-Time | All-Time | -359.5% | +50.9% | at high | +116.5% | -558.8% | +51.6% |
AKRO Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $79.34M(+116.5%) | -$314.50M(+51.6%) |
| Mar 2025 | - | -$482.18M(-3257.3%) | -$649.74M(-492.2%) |
| Dec 2024 | -$109.71M(+50.9%) | $15.27M(-79.1%) | -$109.71M(+2.2%) |
| Sep 2024 | - | $73.07M(+128.6%) | -$112.19M(+63.9%) |
| Jun 2024 | - | -$255.90M(-542.4%) | -$310.96M(-69.6%) |
| Mar 2024 | - | $57.85M(+352.4%) | -$183.36M(+18.0%) |
| Dec 2023 | -$223.62M(-250.4%) | $12.79M(+110.2%) | -$223.62M(+33.8%) |
| Sep 2023 | - | -$125.70M(+2.0%) | -$337.85M(-61.5%) |
| Jun 2023 | - | -$128.30M(-829.4%) | -$209.16M(-203.2%) |
| Mar 2023 | - | $17.59M(+117.3%) | -$68.98M(-8.1%) |
| Dec 2022 | -$63.83M(-251.0%) | -$101.44M(-3481.5%) | -$63.83M(-228.6%) |
| Sep 2022 | - | $3.00M(-74.7%) | $49.62M(-27.6%) |
| Jun 2022 | - | $11.87M(-47.8%) | $68.55M(+48.9%) |
| Mar 2022 | - | $22.75M(+89.6%) | $46.03M(+8.9%) |
| Dec 2021 | $42.28M | $12.00M(-45.3%) | $42.28M(-12.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $21.93M(+305.9%) | $48.18M(+243.4%) |
| Jun 2021 | - | -$10.65M(-156.1%) | -$33.60M(-316.5%) |
| Mar 2021 | - | $19.00M(+6.2%) | $15.52M(+259.0%) |
| Dec 2020 | -$9.76M(+86.4%) | $17.90M(+129.9%) | -$9.76M(+90.2%) |
| Sep 2020 | - | -$59.84M(-255.6%) | -$99.17M(-152.2%) |
| Jun 2020 | - | $38.47M(+712.4%) | -$39.33M(+49.4%) |
| Mar 2020 | - | -$6.28M(+91.2%) | -$77.79M(-8.8%) |
| Dec 2019 | -$71.51M(-1330.3%) | -$71.51M(>-9900.0%) | -$71.51M(>-9900.0%) |
| Sep 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(+100.0%) |
| Mar 2019 | - | $0.00(0.0%) | -$5.00M(0.0%) |
| Dec 2018 | -$5.00M(>-9900.0%) | $0.00(0.0%) | -$5.00M(0.0%) |
| Sep 2018 | - | $0.00(+100.0%) | -$5.00M(0.0%) |
| Jun 2018 | - | -$5.00M(>-9900.0%) | -$5.00M(>-9900.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Akero Therapeutics, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual cash from investing year-on-year change?
- What is Akero Therapeutics, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly cash from investing year-on-year change?
- What is Akero Therapeutics, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM cash from investing year-on-year change?
What is Akero Therapeutics, Inc. annual cash from investing?
The current annual cash from investing of AKRO is -$109.71M
What is the all-time high annual cash from investing for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual cash from investing is $42.28M
What is Akero Therapeutics, Inc. annual cash from investing year-on-year change?
Over the past year, AKRO annual cash from investing has changed by +$113.92M (+50.94%)
What is Akero Therapeutics, Inc. quarterly cash from investing?
The current quarterly cash from investing of AKRO is $79.34M
What is the all-time high quarterly cash from investing for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly cash from investing is $79.34M
What is Akero Therapeutics, Inc. quarterly cash from investing year-on-year change?
Over the past year, AKRO quarterly cash from investing has changed by +$335.24M (+131.00%)
What is Akero Therapeutics, Inc. TTM cash from investing?
The current TTM cash from investing of AKRO is -$314.50M
What is the all-time high TTM cash from investing for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM cash from investing is $68.55M
What is Akero Therapeutics, Inc. TTM cash from investing year-on-year change?
Over the past year, AKRO TTM cash from investing has changed by -$3.55M (-1.14%)